WALLONIA-BIOMED — LIV — CER (Q4027005)

From EU Knowledge Graph
Revision as of 21:18, 17 January 2022 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination., translated_summary)
Jump to navigation Jump to search
Project Q4027005 in Belgium
Language Label Description Also known as
English
WALLONIA-BIOMED — LIV — CER
Project Q4027005 in Belgium

    Statements

    country
    Belgium
    0 references
    EU contribution
    61,071.2 Euro
    0 references
    budget
    152,678.0 Euro
    0 references
    co-financing rate
    40.0 percent
    0 references
    start time
    15 May 2014
    0 references
    end time
    31 December 2023
    0 references
    beneficiary name (string)
    CER-Groupe
    0 references
    beneficiary
    Q4023328
    0 references
    programme
    Wallonia - ERDF
    0 references
    coordinate location

    50°11'10.64"N, 5°17'59.03"E
    0 references
    postal code
    6900
    0 references
    summary
    Développement d'un projet de recherche dans le domaine de la régulation moléculaire de la différenciation des lymphocytes T pour l'immunothérapie et la vaccination. (French)
    0 references
    Development of a research project in the field of molecular regulation of T lymphocyte differentiation for immunotherapy and vaccination. (English)
    point in time
    17 January 2022
    0 references

    Identifiers

    Belgian Kohesio ID
    WAL-875
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q4027005&oldid=23092535"